Cleared Traditional

Tigon Medical Tissue Anchors (K182507) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K182507 · Tigon Medical · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2019
Decision
131d
Days
Class 2
Risk

K182507 is an FDA 510(k) clearance for the Tigon Medical Tissue Anchors. Classified as Fastener, Fixation, Nondegradable, Soft Tissue within the MBI classification (a category for soft tissue fixation fasteners and anchoring systems), Class II - Special Controls.

Submitted by Tigon Medical (Severna Park, US). The FDA issued a Cleared decision on January 21, 2019 after a review of 131 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Tigon Medical devices

Submission Details

510(k) Number K182507 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 2018
Decision Date January 21, 2019
Days to Decision 131 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 122d · This submission: 131d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MBI Fastener, Fixation, Nondegradable, Soft Tissue
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3040
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Intrepid Orthopedics, LLC
Lee Strnad

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MBI Fastener, Fixation, Nondegradable, Soft Tissue

All 321
Devices cleared under the same product code (MBI) and FDA review panel - the closest regulatory comparables to K182507.
HEALIX ADVANCE SP PEEK Anchor
K182941 · Medos International SARL · Feb 2019
HEALIX Ti ANCHOR with DYNACORD
K183279 · Medos International SARL · Feb 2019
Parcus GFS BTB
K183331 · Parcus Medical, LLC · Feb 2019
Responsive Arthroscopy Wedge Push-In Suture Anchors
K181076 · Responsive Arthroscopy, LLC · Jan 2019
TenoTac Soft Tissue Fixation System
K182898 · Paragon 28, Inc. · Jan 2019
Cortical Fixation Systems
K181086 · Cousin Biotech Sas · Jan 2019